2nd Next Gen Inhalation Delivery Summit

Temi della conferenza
In an era marked by remarkable advancements, the inhalation therapy field is rapidly evolving. From Avalyn's $175 million investment in inhaled pulmonary fibrosis trials to Krystal Biotech's FDA clearance for inhaled gene therapy and MIT engineers' work on inhaled nanoparticles, the field is abuzz with new advances and breakthroughs in inhalation delivery.

Professional congress organizer (PCO)
Hanson Wade

Annotazioni
URL:
Brochure: https://go.evvnt.com/2262398-0?pid=4832

Speakers: Anna Cheng, Director - R and D Pulmonary Drug Delivery, Feldan Therapeutics , Colin Scott, CEO, Highland Airs Consultancy, Jaap Wieling, CEO, PureIMS, and more

Ms. Nandita Iyer